MilliporeSigma Invests $286-Million in Drug Safety Testing Capacity of the US

MilliporeSigma, Canada and US life science businesses of Merck KGaA, Germany, a leading science and technology company, announced that its life science business industry is investing over 286 million dollars in the biosafety testing capacity at the company’s site in Rockville, USA. This investment will significantly increase the ability of the company to conduct biosafety […]

Continue Reading

Cizzle Biotechnology Announced Partnership With Behnke Group To Enhance Market Presence In US

Cizzle Biotechnology Holdings PLC, which is a diagnostics developer based in the United Kingdom, is very happy for announcing that, it has now entered into an agreement along with the Behnke Group, which is a healthcare consulting company based in Texas, US with having decades of experience collaborating with the healthcare organizations across the United […]

Continue Reading

PrecisionLife Limited And Sano Genetics To Accelerate Genetics Understanding Of Long Covid-19

PrecisionLife Limited, a techbio company using the company’s deep insights into the disease biology and patient stratification for the purpose of driving the precision medicine in the chronic diseases, has announced a partnership with Sano Genetics, a genetic research platform enabling the patients for participating in the ethical research projects for advancing the understanding of […]

Continue Reading

Oppilotech and Evariste Technologies Partnered to Develop First-in-Class Antibacterial Programme

Oppilotech Ltd., a biotechnology company specializing in the systems biology and the machine learning platforms for the purpose of building the unique predictive computational models of cells has announced a partnership of co-development drug discovery with Evariste Technologies based in United Kingdom, that is going to be using the artificial intelligence and machine learning technologies […]

Continue Reading

XORTX Therapeutics Submits Clinical Trial Application To Conduct Study on PharmacoKinetics

XORTX Therapeutics Inc., a pharmaceutical therapeutics company that is focusing on the development of the innovative therapies for the purpose of treating the progressive kidney disease announced that, it has submitted a clinical trial application (CTA) along with the Health Canada for a study of XRX-OXY-101 bridging pharmacokinetics. The XRX-OXY-101 Bridging Pharmacokinetics Study has been […]

Continue Reading